• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活剂及其受体的表达在肌腱愈合过程中上调。

Expression of urokinase-type plasminogen activator and its receptor is up-regulated during tendon healing.

作者信息

Xia Wei, de Bock Charles, Murrell George A C, Wang Yao

机构信息

Orthopaedic Research Institute, The St. George Hospital, University of New South Wales, Kogarah, Sydney, NSW 2217, Australia .

出版信息

J Orthop Res. 2003 Sep;21(5):819-25. doi: 10.1016/S0736-0266(03)00058-5.

DOI:10.1016/S0736-0266(03)00058-5
PMID:12919869
Abstract

The urokinase-type plasminogen activator (uPA) system has been implicated in cell migration, angiogenesis, extracellular matrix synthesis and tissue remodelling. However, little is known about the role of the system in tendon healing. We used a rat Achilles tendon model to study mRNA and protein expression of uPA and its receptor (uPAR) during tendon healing using immunohistochemical, Northern and Western blot analyses. Time-dependent increases in uPA/uPAR mRNAs and proteins, maximal on days 4-7 and 7-14 respectively, were found following Achilles tendon division. Interestingly, uninjured control tendons expressed uPA mRNA and protein, but little uPAR transcripts and protein. On day 14 following Achilles tendon division, uPA receptor protein increased 12.6-fold (p<0.001) while uPA itself increased only 1.3-fold (p<0.05). Immunohistochemical analyses revealed that both uPAR/uPA positive staining cells were increased in the healing tendon tissue section. These findings show for the first time that uPA, and especially its receptor uPAR, are up-regulated during tendon healing.

摘要

尿激酶型纤溶酶原激活剂(uPA)系统与细胞迁移、血管生成、细胞外基质合成及组织重塑有关。然而,该系统在肌腱愈合中的作用却鲜为人知。我们使用大鼠跟腱模型,通过免疫组织化学、Northern印迹和Western印迹分析,研究肌腱愈合过程中uPA及其受体(uPAR)的mRNA和蛋白表达。跟腱切断后,发现uPA/uPAR的mRNA和蛋白呈时间依赖性增加,分别在第4 - 7天和第7 - 14天达到最大值。有趣的是,未受伤的对照肌腱表达uPA的mRNA和蛋白,但uPAR的转录本和蛋白很少。跟腱切断后第14天,uPA受体蛋白增加了12.6倍(p<0.001),而uPA本身仅增加了1.3倍(p<0.05)。免疫组织化学分析显示,愈合肌腱组织切片中uPAR/uPA阳性染色细胞均增加。这些发现首次表明,在肌腱愈合过程中uPA,尤其是其受体uPAR上调。

相似文献

1
Expression of urokinase-type plasminogen activator and its receptor is up-regulated during tendon healing.尿激酶型纤溶酶原激活剂及其受体的表达在肌腱愈合过程中上调。
J Orthop Res. 2003 Sep;21(5):819-25. doi: 10.1016/S0736-0266(03)00058-5.
2
In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.尿激酶型纤溶酶原激活剂及其受体在人膀胱移行细胞癌中的原位基因表达
Oncol Rep. 2004 Oct;12(4):909-13.
3
Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.大鼠糖尿病肾病中尿激酶型纤溶酶原激活物、其受体及纤溶酶原激活物抑制剂-1的肾脏合成:血管紧张素转换酶抑制剂的调节作用
J Lab Clin Med. 2004 Aug;144(2):69-77. doi: 10.1016/j.lab.2004.04.002.
4
Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.尿激酶型纤溶酶原激活剂及其受体在人肾细胞癌中的差异基因表达
Oncol Rep. 2005 Sep;14(3):777-82.
5
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.月经周期中子宫内膜组织中尿激酶型纤溶酶原激活剂(uPA)、其受体(uPAR)及其抑制剂(PAI-1)mRNA和蛋白的差异定位与表达。
Mol Hum Reprod. 2004 Sep;10(9):655-63. doi: 10.1093/molehr/gah081. Epub 2004 Jul 8.
6
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.
7
Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.尿激酶型纤溶酶原激活物、纤溶酶原激活物受体及纤溶酶原激活物抑制剂-2在正常人体子宫内膜和子宫内膜癌中的mRNA差异表达
Gynecol Oncol. 2000 Nov;79(2):244-50. doi: 10.1006/gyno.2000.5959.
8
[Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].[负压封闭引流对急慢性伤口愈合中尿激酶型纤溶酶原激活剂及尿激酶型纤溶酶原激活剂受体表达的影响]
Zhonghua Zheng Xing Wai Ke Za Zhi. 2006 Jul;22(4):306-9.
9
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.乳腺肿瘤组织基质中的尿激酶系统与乳腺癌细胞侵袭
Int J Oncol. 2009 Jan;34(1):15-23.
10
Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.与尿激酶、其受体和纤溶酶原激活物抑制剂-1不同,上皮组织型纤溶酶原激活物的表达在慢性静脉溃疡中增加。
Br J Dermatol. 2004 Dec;151(6):1189-96. doi: 10.1111/j.1365-2133.2004.06261.x.

引用本文的文献

1
Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.羊膜间充质基质细胞分泌因子和细胞外囊泡-miRNAs:肌肉骨骼组织的抗炎和再生特性。
Stem Cells Transl Med. 2021 Jul;10(7):1044-1062. doi: 10.1002/sctm.20-0390. Epub 2021 Mar 3.
2
Oral Ibuprofen Interferes with Cellular Healing Responses in a Murine Model of Achilles Tendinopathy.口服布洛芬会干扰跟腱病小鼠模型中的细胞愈合反应。
J Musculoskelet Disord Treat. 2018;4(2). doi: 10.23937/2572-3243.1510049. Epub 2018 May 21.
3
Cellular distribution and gene expression profile during flexor tendon graft repair: A novel tissue engineering approach(*).
在屈肌腱移植物修复过程中的细胞分布和基因表达谱:一种新的组织工程方法(*)。
J Tissue Eng. 2013 Jun 9;4:2041731413492741. doi: 10.1177/2041731413492741. Print 2013.
4
Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.针对尿激酶型纤溶酶原激活物受体 (uPAR) 的新型治疗药物的开发及其向临床的转化。
Curr Pharm Des. 2011;17(19):1970-8. doi: 10.2174/138161211796718152.
5
Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.纤溶酶原激活物抑制剂1在作为可溶性因子以及作为肺泡上皮细胞伤口愈合的基质细胞调节因子方面的双重作用。
Am J Pathol. 2006 Nov;169(5):1624-32. doi: 10.2353/ajpath.2006.051053.